Kenvue faces challenges with declining sales, cash flow risks, and high leverage. Read here for more analysis on KVUE stock.

CEO Debra Crew has stepped down after two years in the job, the world's biggest spirits maker has said, with finance chief Nik Jhangiani taking over in the interim as the company strives to boost its ...

When investors are attempting to find the best stocks to buy now, they should look beyond factors such as company size (small ...

By Pushkala Aripaka and Emma Rumney (Reuters) -Diageo CEO Debra Crew has stepped down after two years in the job, the world's biggest spirits maker said on Wednesday, with finance chief Nik Jhangiani ...

Kenvue, which was spun off from Johnson & Johnson in 2023, has been working to shore up profitability, especially in its ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...

BAND-AID and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent sales slump.

Among the suitors are the billionaire telecom moguls Martin Bouygues and Iliad-owner Xavier Niel. Orange is also hoping for a slice of the pie, but France’s largest telecom would face significant ...